“Eli Lilly Stock Plummets Following Disappointing GLP-1 Sales Report in 2025”
Eli Lilly’s Dominance in Healthcare The Rise of Eli Lilly Eli Lilly, a pharmaceutical giant, has solidified its position in the healthcare industry. With the success of its GLP-1 drugs, Mounjaro and Zepbound, the company’s market capitalization has soared to an impressive $650 billion. This newfound success has transformed Eli Lilly into a formidable force…